Aktis Oncology Inc (AKTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Sales | 3,227 | 0 | 1,447 |
| Gross Profit | 3,227 | N/A | 1,447 |
| Operating Expenses | 25,933 | 0 | 19,590 |
| Operating Income | -22,706 | N/A | -18,143 |
| Other Income | 4,381 | 0 | 3,158 |
| Pre-tax Income | -18,325 | 0 | -14,985 |
| Net Income Continuous | -18,325 | N/A | -14,985 |
| Net Income | $-18,325 | $N/A | $-14,985 |
| EPS Basic Total Ops | -0.38 | N/A | -18.60 |
| EPS Basic Continuous Ops | -0.38 | N/A | -18.60 |
| EPS Diluted Total Ops | -0.38 | N/A | -18.60 |
| EPS Diluted Continuous Ops | -0.38 | N/A | -18.60 |
| EPS Diluted Before Non-Recurring Items | -0.38 | N/A | -0.14 |
| EBITDA(a) | $-22,583 | $N/A | $-19,513 |